Renal vein thrombosis after <scp>COVID</scp>‐19: A case report

Roudsari, Hamid Janbazi; Negaresh, Mohammad; Shirzadeh, Vida; Germi, Bahman Mohammadzadeh; Mirzaei, Arezoo

doi:10.1002/ccr3.6778

Cited by 4 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diverse renal manifestations reported worldwide include acute tubular necrosis (ATN), collapsing focal segmental glomerulosclerosis, albuminuria, hematuria, electrolyte derangements [98], minimal change disease, crescentic glomerulonephritis, thrombotic thrombocytopenic purpura (TTP), atypical hemolytic uremic syndrome (aHUS), IgA nephropathy, renal vein thrombosis, diffuse proliferative glomerulonephritis, acute kidney injury [106][107][108][109][110].…”

Section: Renal Manifestationsmentioning

confidence: 99%

From Emergence to Endemicity: A Comprehensive Review of COVID-19

Naik,

Avula,

Palleti

et al. 2023

Cureus

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), later renamed coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in early December 2019. Initially, the China office of the World Health Organization was informed of numerous cases of pneumonia of unidentified etiology in Wuhan, Hubei Province at the end of 2019. This would subsequently result in a global pandemic with millions of confirmed cases of COVID-19 and millions of deaths reported to the WHO. We have analyzed most of the data published since the beginning of the pandemic to compile this comprehensive review of SARS-CoV-2. We looked at the core ideas, such as the etiology, epidemiology, pathogenesis, clinical symptoms, diagnostics, histopathologic findings, consequences, therapies, and vaccines. We have also included the long-term effects and myths associated with some therapeutics of COVID-19. This study presents a comprehensive assessment of the SARS-CoV-2 virology, vaccines, medicines, and significant variants identified during the course of the pandemic. Our review article is intended to provide medical practitioners with a better understanding of the fundamental sciences, clinical treatment, and prevention of COVID-19. As of May 2023, this paper contains the most recent data made accessible.

show abstract

Section: Renal Manifestationsmentioning

confidence: 99%

From Emergence to Endemicity: A Comprehensive Review of COVID-19

Naik,

Avula,

Palleti

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…COVID-19 has also been associated with some cases of RVT, which is attributed to the ability of the virus to cause direct harm to the endothelium and trigger an overactive inflammatory response [ 1 , 2 ]. There have been documented case reports highlighting the occurrence of RVT in patients diagnosed with COVID-19 [ 4 , 5 ].…”

Section: Discussionmentioning

confidence: 99%

Renal Vein Thrombosis Treated With Apixaban in a Patient With COVID-19: A Case Report

Kakhktsyan,

Mousa,

Arshad

et al. 2023

Cureus

View full text Add to dashboard Cite

Renal vein thrombosis (RVT) is a rare condition characterized by the formation of a blood clot in one or both of the renal veins. Bilateral involvement is more common, but when the condition affects only one side, it usually occurs on the left due to more extensive venous vasculature compared to the right side. RVT can be caused by various factors such as trauma, dehydration, malignancy, and a hypercoagulable state. Acute RVT is typically more severe than chronic, and it can cause symptoms such as renal infarction, acute kidney injury, renal failure, severe flank pain, and hematuria. Some cases of RVT have also been linked to coronavirus disease 2019 (COVID-19), which is widely recognized to induce a hypercoagulable state. The standard treatment for RVT is warfarin but in this case report, we describe a COVID-19 patient with RVT whose thrombus was successfully treated with direct-acting oral anticoagulant (DOAC) apixaban for six months.

show abstract

“…Renal manifestations: Diverse renal manifestations reported worldwide include acute tubular necrosis (ATN), collapsing focal segmental glomerulosclerosis, albuminuria, hematuria, electrolyte derangements (98), minimal change disease, crescentic glomerulonephritis, thrombotic thrombocytopenic purpura (TTP), atypical hemolytic uremic syndrome (aHUS), IgA nephropathy, renal vein thrombosis, diffuse proliferative glomerulonephritis, acute kidney injury (106)(107)(108)(109)(110).…”

Section: Skinmentioning

confidence: 99%

COVID-19: From Emergence to Endemicity - A Comprehensive Review

Naik,

Avula,

Palleti

et al. 2023

Preprint

View full text Add to dashboard Cite

Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2), later renamed Coronavirus Disease 2019 (COVID-19) was first identified in Wuhan, China, in early December 2019. Initially, the China office of the World Health Organization was informed of numerous cases of pneumonia of unidentified etiology in Wuhan, Hubei Province on December 31, 2019. This would subsequently result in a global pandemic with over 76 million confirmed cases of COVID-19 and 6.9 million deaths reported to the WHO. We have analyzed most of the data published since the beginning of the pandemic to compile this comprehensive review of SARS-CoV-2. We look at the core ideas, such as the etiology, epidemiology, pathogenesis, clinical symptoms, diagnostics, histopathologic findings, consequences, therapies, and vaccines. We have also included the long-term effects and myths associated with some therapeutics of COVID-19. This study comprehensively assesses of the SARS-CoV-2 virology, vaccines, medicines, and significant variants identified during the pandemic. Our review article is intended to provide medical practitioners with a better understanding of the fundamental sciences, clinical treatment, and prevention of COVID-19. As of June 2023, this paper contains the most recent data made accessible.

show abstract

Renal vein thrombosis after COVID‐19: A case report

Cited by 4 publications

References 11 publications

From Emergence to Endemicity: A Comprehensive Review of COVID-19

From Emergence to Endemicity: A Comprehensive Review of COVID-19

Renal Vein Thrombosis Treated With Apixaban in a Patient With COVID-19: A Case Report

COVID-19: From Emergence to Endemicity - A Comprehensive Review

Contact Info

Product

Resources

About